Grant J. Logan

1.0k total citations
37 papers, 767 citations indexed

About

Grant J. Logan is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Grant J. Logan has authored 37 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 18 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Grant J. Logan's work include Virus-based gene therapy research (18 papers), CRISPR and Genetic Engineering (8 papers) and Immune Cell Function and Interaction (7 papers). Grant J. Logan is often cited by papers focused on Virus-based gene therapy research (18 papers), CRISPR and Genetic Engineering (8 papers) and Immune Cell Function and Interaction (7 papers). Grant J. Logan collaborates with scholars based in Australia, United Kingdom and United States. Grant J. Logan's co-authors include Ian E. Alexander, Sharon C. Cunningham, Patrick Tam, John Christodoulou, Leszek Lisowski, Hilda A. Pickett, Gustavo de Alencastro, Melinda Power, Keren Kaufman‐Francis and Joshua B. Studdert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Grant J. Logan

33 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant J. Logan Australia 15 529 308 120 78 67 37 767
Bernard Gjata France 15 375 0.7× 330 1.1× 141 1.2× 153 2.0× 50 0.7× 26 694
Linqing Sun China 8 471 0.9× 272 0.9× 70 0.6× 70 0.9× 30 0.4× 14 611
Gabriella Cotugno Italy 17 383 0.7× 316 1.0× 161 1.3× 184 2.4× 58 0.9× 37 792
Manuela González-Aparicio Spain 13 282 0.5× 228 0.7× 187 1.6× 200 2.6× 38 0.6× 24 645
Chuanyin Li China 17 509 1.0× 133 0.4× 98 0.8× 96 1.2× 68 1.0× 71 882
Yutaka Negishi Japan 16 233 0.4× 199 0.6× 71 0.6× 66 0.8× 99 1.5× 37 576
Xuehai Ye United States 11 546 1.0× 533 1.7× 32 0.3× 129 1.7× 64 1.0× 17 763
Marcelo Simon Sola France 8 406 0.8× 428 1.4× 38 0.3× 134 1.7× 28 0.4× 11 621
Zhenning He United States 14 826 1.6× 470 1.5× 25 0.2× 84 1.1× 76 1.1× 23 1.0k
Jude Samulski United States 9 512 1.0× 430 1.4× 34 0.3× 66 0.8× 103 1.5× 12 765

Countries citing papers authored by Grant J. Logan

Since Specialization
Citations

This map shows the geographic impact of Grant J. Logan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant J. Logan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant J. Logan more than expected).

Fields of papers citing papers by Grant J. Logan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant J. Logan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant J. Logan. The network helps show where Grant J. Logan may publish in the future.

Co-authorship network of co-authors of Grant J. Logan

This figure shows the co-authorship network connecting the top 25 collaborators of Grant J. Logan. A scholar is included among the top collaborators of Grant J. Logan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant J. Logan. Grant J. Logan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alikhan, Maliha A., Lu Lu, Kate E. Lawlor, et al.. (2025). Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis. JCI Insight. 10(15).
2.
Mietzsch, Mario, Ang Huang, Nicholas Smith, et al.. (2025). Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts. Nature Communications. 16(1). 3731–3731. 5 indexed citations
3.
Nassif, Najah T., Bronwyn A. O’Brien, Grant J. Logan, et al.. (2025). Pancreatic transdifferentiation of NOD mouse livers prevented development of hyperglycemia. Molecular Therapy. 34(1). 527–539.
4.
Mallett, Grace, Isabel Y. Pappworth, Grant J. Logan, et al.. (2025). AAV-mHDM-FH: Safety and expression profile in two murine models of hyper-complement activation. Immunobiology. 230(4). 153002–153002.
5.
Logan, Grant J., Mario Mietzsch, Arlene D’Silva, et al.. (2023). Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy. Molecular Therapy. 31(7). 1979–1993. 19 indexed citations
6.
Lee, Jayden, et al.. (2023). Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 24(13). 11118–11118. 1 indexed citations
7.
O’Sullivan, Kim M., Christine M. Smyth, Helen Doyle, et al.. (2022). Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus Erythematosus. Human Gene Therapy. 33(9-10). 560–571. 2 indexed citations
8.
Rao, Renuka, Grant J. Logan, Cindy Kok, et al.. (2022). Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method. Viruses. 14(8). 1623–1623. 2 indexed citations
9.
Malik, Talat H., Daniel P. Gitterman, Deborah Lavin, et al.. (2021). Gain-of-function factor H–related 5 protein impairs glomerular complement regulation resulting in kidney damage. Proceedings of the National Academy of Sciences. 118(13). 17 indexed citations
10.
Smyth, Christine M., Helen Doyle, Talat H. Malik, et al.. (2021). Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway In Vivo. Human Gene Therapy. 32(21-22). 1370–1381. 7 indexed citations
11.
Cabanes‐Creus, Marti, Claus V. Hallwirth, Adrian Westhaus, et al.. (2020). Restoring the natural tropism of AAV2 vectors for human liver. Science Translational Medicine. 12(560). 33 indexed citations
12.
Logan, Grant J., Sharon C. Cunningham, Najah T. Nassif, et al.. (2020). Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice. Cells. 9(10). 2227–2227. 9 indexed citations
13.
Ginn, Samantha L., Anais K. Amaya, Sophia H.Y. Liao, et al.. (2019). Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes. JHEP Reports. 2(1). 100065–100065. 24 indexed citations
14.
Wang, Jiang-Hui, Veluchamy A. Barathi, Zheng He, et al.. (2018). AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization. Angiogenesis. 21(1). 95–109. 21 indexed citations
15.
Wang, Chuanmin, Szun S. Tay, Claire McGuffog, et al.. (2018). Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction. JCI Insight. 3(15). 13 indexed citations
16.
Logan, Grant J., Allison Dane, Claus V. Hallwirth, et al.. (2017). Identification of liver-specific enhancer–promoter activity in the 3′ untranslated region of the wild-type AAV2 genome. Nature Genetics. 49(8). 1267–1273. 77 indexed citations
17.
Dane, Allison, Sharon C. Cunningham, Cindy Kok, Grant J. Logan, & Ian E. Alexander. (2015). Transient suppression of hepatocellular replication in the mouse liver following transduction with recombinant adeno-associated virus. Gene Therapy. 22(11). 917–922. 1 indexed citations
18.
Kojima, Yoji, Keren Kaufman‐Francis, Joshua B. Studdert, et al.. (2013). The Transcriptional and Functional Properties of Mouse Epiblast Stem Cells Resemble the Anterior Primitive Streak. Cell stem cell. 14(1). 107–120. 221 indexed citations
19.
Chung, Henry, Ruby C.Y. Lin, Grant J. Logan, et al.. (2011). Human Induced Pluripotent Stem Cells Derived Under Feeder-Free Conditions Display Unique Cell Cycle and DNA Replication Gene Profiles. Stem Cells and Development. 21(2). 206–216. 20 indexed citations
20.
Alexander, Ian E., Sharon C. Cunningham, Grant J. Logan, & John Christodoulou. (2008). Potential of AAV vectors in the treatment of metabolic disease. Gene Therapy. 15(11). 831–839. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Gjata Breakdown of academic impact, for papers by Linqing Sun Breakdown of academic impact, for papers by Gabriella Cotugno Breakdown of academic impact, for papers by Manuela González-Aparicio Breakdown of academic impact, for papers by Chuanyin Li Breakdown of academic impact, for papers by Yutaka Negishi Breakdown of academic impact, for papers by Xuehai Ye Breakdown of academic impact, for papers by Marcelo Simon Sola Breakdown of academic impact, for papers by Zhenning He Breakdown of academic impact, for papers by Jude Samulski
Rankless by CCL
2026